世界の人工血管開発動向:医療機器パイプライン分析2015

◆英語タイトル:Vascular Grafts - Medical Devices Pipeline Assessment, 2015
◆商品コード:GDME0109EPD
◆発行会社(調査会社):GlobalData
◆発行日:2015年12月1日
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥535,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥802,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、人工血管のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。

・人工血管の概要
・人工血管の開発動向:開発段階別分析
・人工血管の開発動向:セグメント別分析
・人工血管の開発動向:領域別分析
・人工血管の開発動向:規制Path別分析
・人工血管の開発動向:承認日(推定)別分析
・企業別人工血管の開発動向(パイプライン製品、進行中の治験)
・人工血管の最近動向
【レポートの概要】

Vascular Grafts – Medical Devices Pipeline Assessment, 2015

Summary

GlobalData’s Medical Devices sector report, “Vascular Grafts – Medical Devices Pipeline Assessment, 2015″ provides an overview of Vascular Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vascular Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Vascular Grafts under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Vascular Grafts under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Vascular Grafts Overview 7
3 Products under Development 8
3.1 Vascular Grafts – Pipeline Products by Stage of Development 8
3.2 Vascular Grafts – Pipeline Products by Territory 9
3.3 Vascular Grafts – Pipeline Products by Regulatory Path 10
3.4 Vascular Grafts – Pipeline Products by Estimated Approval Date 11
3.5 Vascular Grafts – Ongoing Clinical Trials 12
4 Vascular Grafts – Pipeline Products under Development by Companies 13
4.1 Vascular Grafts Companies – Pipeline Products by Stage of Development 13
4.2 Vascular Grafts – Pipeline Products by Stage of Development 14
5 Vascular Grafts Companies and Product Overview 15
5.1 3S BioMedical, Inc. Company Overview 15
5.1.1 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Anethon (Inactive) Company Overview 17
5.2.1 Anethon (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 17
5.3 ARISTE Medical Company Overview 18
5.3.1 ARISTE Medical Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Cardiojustable LLC Company Overview 20
5.4.1 Cardiojustable LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.5 CryoLife, Inc. Company Overview 21
5.5.1 CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.6 DSM Biomedical B.V. Company Overview 23
5.6.1 DSM Biomedical B.V. Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 Eqalix, Inc. Company Overview 24
5.7.1 Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.8 FIT Biotech Oy Company Overview 26
5.8.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 26
5.9 Gel-Del Technologies, Inc. Company Overview 28
5.9.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
5.10 Graftworx, LLC Company Overview 29
5.10.1 Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
5.11 Healionics Corporation Company Overview 30
5.11.1 Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
5.12 Innovia LLC Company Overview 31
5.12.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 31
5.13 MultiGene Vascular Systems (MGVS) Ltd. Company Overview 32
5.13.1 MultiGene Vascular Systems (MGVS) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32
5.14 NuVascular Technologies Inc Company Overview 34
5.14.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 34
5.15 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 35
5.15.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 35
5.16 SurgaColl Technologies Ltd Company Overview 36
5.16.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.17 Universidad de Los Andes Company Overview 37
5.17.1 Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 37
5.18 VesselTek BioMedical LLC Company Overview 38
5.18.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 38
5.19 Xeltis AG Company Overview 41
5.19.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 41
6 Vascular Grafts- Recent Developments 44
7 Appendix 46
7.1 Methodology 46
7.2 About GlobalData 48
7.3 Contact Us 49
7.4 Disclaimer 49

1.1 List of Tables
Table 1: Vascular Grafts - Pipeline Products by Stage of Development 8
Table 2: Vascular Grafts - Pipeline Products by Territory 9
Table 3: Vascular Grafts - Pipeline Products by Regulatory Path 10
Table 4: Vascular Grafts - Pipeline Products by Estimated Approval Date 11
Table 5: Vascular Grafts - Ongoing Clinical Trials 12
Table 6: Vascular Grafts Companies - Pipeline Products by Stage of Development 13
Table 7: Vascular Grafts - Pipeline Products by Stage of Development 14
Table 8: 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 15
Table 9: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Status 15
Table 10: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Description 15
Table 11: Resorpor AdvaMatrixrPro Vessel Graft - Product Status 16
Table 12: Resorpor AdvaMatrixrPro Vessel Graft - Product Description 16
Table 13: Anethon (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 17
Table 14: Anethon Blood Vessel - Product Status 17
Table 15: Anethon Blood Vessel - Product Description 17
Table 16: ARISTE Medical Pipeline Products & Ongoing Clinical Trials Overview 18
Table 17: Drug Eluting Vascular Graft - Product Status 19
Table 18: Drug Eluting Vascular Graft - Product Description 19
Table 19: Cardiojustable LLC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 20: Adjustable Vascular Graft - Product Status 20
Table 21: Adjustable Vascular Graft - Product Description 20
Table 22: CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
Table 23: Synergraft Xenograft Vascular Graft - Product Status 22
Table 24: Synergraft Xenograft Vascular Graft - Product Description 22
Table 25: DSM Biomedical B.V. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 26: Small Diameter Vascular Graft - Product Status 23
Table 27: Small Diameter Vascular Graft - Product Description 23
Table 28: Eqalix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 29: CardioVessel - Product Status 24
Table 30: CardioVessel - Product Description 24
Table 31: LCL Graft - Product Status 25
Table 32: LCL Graft - Product Description 25
Table 33: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 26
Table 34: GTU X-Graft - Product Status 26
Table 35: GTU X-Graft - Product Description 26
Table 36: GTU X2-Graft - Product Status 27
Table 37: GTU X2-Graft - Product Description 27
Table 38: Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
Table 39: VasoGraft - Product Status 28
Table 40: VasoGraft - Product Description 28
Table 41: Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview 29
Table 42: Smart Graft - Product Status 29
Table 43: Smart Graft - Product Description 29
Table 44: Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 30
Table 45: STARgraft - Vascular Reconstruction - Product Status 30
Table 46: STARgraft - Vascular Reconstruction - Product Description 30
Table 47: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 31
Table 48: 4mm Vascular Graft - Product Status 31
Table 49: 4mm Vascular Graft - Product Description 31
Table 50: MultiGene Vascular Systems (MGVS) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 51: MultiGeneGraft - Product Status 33
Table 52: MultiGeneGraft - Product Description 33
Table 53: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 34
Table 54: BioFunc - APC Vascular Graft - Product Status 34
Table 55: BioFunc - APC Vascular Graft - Product Description 34
Table 56: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 35
Table 57: Enhanced Vascular Graft - Product Status 35
Table 58: Enhanced Vascular Graft - Product Description 35
Table 59: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
Table 60: CardioColl - Product Status 36
Table 61: CardioColl - Product Description 36
Table 62: Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 37
Table 63: SiSgraft - Product Status 37
Table 64: SiSgraft - Product Description 37
Table 65: VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 38
Table 66: VTek Graft - Product Status 38
Table 67: VTek Graft - Product Description 38
Table 68: VTek-RA Graft - Product Status 39
Table 69: VTek-RA Graft - Product Description 39
Table 70: VTek-RA Wrap - Product Status 40
Table 71: VTek-RA Wrap - Product Description 40
Table 72: Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 41
Table 73: Endogenous Tissue Growth Implant - Product Status 41
Table 74: Endogenous Tissue Growth Implant - Product Description 41
Table 75: Xeltis AG - Ongoing Clinical Trials Overview 42
Table 76: Endogenous Tissue Growth Implant - Initial Safety and Performance of the COR-VP-001 Vascular Patch in Pediatric Patients Undergoing the Right Ventricular Outflow Tract (RVOT) Reconstruction 43
Table 77: Glossary 47

1.2 List of Figures
Figure 1: Vascular Grafts - Pipeline Products by Stage of Development 8
Figure 2: Vascular Grafts - Pipeline Products by Territory 9
Figure 3: Vascular Grafts - Pipeline Products by Regulatory Path 10
Figure 4: Vascular Grafts - Pipeline Products by Estimated Approval Date 11
Figure 5: Vascular Grafts - Ongoing Clinical Trials 12

【掲載企業】

3S BioMedical, Inc.
ARISTE Medical
Cardiojustable LLC
CryoLife, Inc.
DSM Biomedical B.V.
Eqalix, Inc.
FIT Biotech Oy
Gel-Del Technologies, Inc.
Graftworx, LLC
Healionics Corporation
Innovia LLC
MultiGene Vascular Systems (MGVS) Ltd.
NuVascular Technologies Inc
Sree Chitra Tirunal Institute for Medical Sciences & Technology
SurgaColl Technologies Ltd
Universidad de Los Andes
VesselTek BioMedical LLC
Xeltis AG

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[世界の人工血管開発動向:医療機器パイプライン分析2015]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年07月24日現在 197,351 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆